Research Report: CERITER Clinical Study - Stride One
1 other identifier
interventional
10
1 country
1
Brief Summary
The goal of this clinical study is to investigate the short-term impact of the use of Ceriter Stride One on the quality of gait in patients rehabilitating after a cerebrovascular accident (CVA). Stride One is a smart insole that provides real-time audio feedback (cues) to the patient when performing a certain exercise. The main questions it aims to answer are:
- Will patients with a CVA show a qualitatively better gait pattern after training with a Stride One insole?
- Can patients maintain this improvement in gait pattern without audio feedback at the end of the training? Participants will
- Receive daily gait rehabilitation using Stride One for 1 week
- The quality of the gait pattern was evaluated at the beginning and at the end of the week, with and without the use of Stride One
- An additional evaluation was performed three to four days after the end of therapy without the use of Stride One
- Immediately after the end of the intervention week, the patient and the treating therapist were asked about their findings regarding the use of Stride One while walking
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 29, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 29, 2024
CompletedFirst Submitted
Initial submission to the registry
August 8, 2024
CompletedFirst Posted
Study publicly available on registry
August 19, 2024
CompletedAugust 19, 2024
August 1, 2024
4 months
August 8, 2024
August 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Complete and correct foot roll-off
The first primary endpoint of the study is the complete and correct foot roll-off (detected and interpreted in the Ceriter platform). Stride One provides auditory feedback to the patient, stimulating the patient to achieve a good roll-off of the foot. For each step it measures whether a correct heel-strike, mid-stance and terminal stance are achieved. The aim of Stride One is to teach patients to place their feet correctly, in order to obtain a better roll- off, using positive audio feedback.
1 week while daily therapy was given
Changed walking speed/greater number of steps per minute
1 week while daily therapy was given
Secondary Outcomes (4)
Improved functional tests: 5x sit-to-stand (seconds)
Before the start of the therapy, immediately after the end of the intervention period and 2 days after the end of the therapy
Improved functional tests: 3-minute walking test without audio feedback
Before the start of the therapy, immediately after the end of the intervention period and 2 days after the end of the therapy
Improved functional tests: 3-minute walking test with audio feedback
Before the start of the therapy and immediately after the end of the intervention period
Subjective experiences: questionnaires
Post intervention, 2 days after end of the therapy
Study Arms (1)
Real-time audio feedback
OTHERPhysiotherapist-defined real-time audio feedback
Interventions
Stride One is a smart insole that provides real-time audio feedback (cues) to the patient when performing a certain exercise. The goal of Stride One is to allow patients to practice walking more intensively and with higher quality during rehabilitation.
Eligibility Criteria
You may qualify if:
- CVA, residentially admitted to the rehabilitation center in Herk-de-Stad, Belgium
- Older than 18 years of age
- Gait problems as a result of the CVA
- Able to walk safely and independently (possibly with a walking aid)
- Able to understand and sign an information and consent form
You may not qualify if:
- Severe cognitive problems (attention) that make it difficult to understand instructions or follow feedback
- Hearing problem
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ceriter Nederland BVlead
- FRAME Jessa Ziekenhuis, Belgiumcollaborator
Study Sites (1)
Frame, Jessa Ziekenhuis
Hasselt, 3500, Belgium
Related Publications (3)
Khoo IH, Marayong P, Krishnan V, Balagtas M, Rojas O, Leyba K. Real-time biofeedback device for gait rehabilitation of post-stroke patients. Biomed Eng Lett. 2017 Jun 7;7(4):287-298. doi: 10.1007/s13534-017-0036-1. eCollection 2017 Nov.
PMID: 30603178BACKGROUNDKwakkel G, Stinear C, Essers B, Munoz-Novoa M, Branscheidt M, Cabanas-Valdes R, Lakicevic S, Lampropoulou S, Luft AR, Marque P, Moore SA, Solomon JM, Swinnen E, Turolla A, Alt Murphy M, Verheyden G. Motor rehabilitation after stroke: European Stroke Organisation (ESO) consensus-based definition and guiding framework. Eur Stroke J. 2023 Dec;8(4):880-894. doi: 10.1177/23969873231191304. Epub 2023 Aug 7.
PMID: 37548025BACKGROUNDKim J, Jung S, Song C. The Effects of Auditory Feedback Gait Training Using Smart Insole on Stroke Patients. Brain Sci. 2021 Oct 21;11(11):1377. doi: 10.3390/brainsci11111377.
PMID: 34827376BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Sarah Meyer
Frame Jessa Ziekenhuis
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 8, 2024
First Posted
August 19, 2024
Study Start
December 18, 2023
Primary Completion
April 29, 2024
Study Completion
April 29, 2024
Last Updated
August 19, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share